Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
You'll receive it via email
Clinical trials have shown that individuals using Wegovy experienced an average weight loss of around 15% of their initial body weight over the course of the trial
When injections or surgery may be a better option For patients seeking more substantial or durable weight loss, injectable medications or bariatric surgery may offer more reliable results
Wegovy is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity
US$ 26.74
US$ 24.59
US$ 29.87
US$ 28.37
US$ 21.22
US$ 21.90
US$ 21.72
US$ 25.81
